| 摘要 |
A pharmaceutical composition is provided for treatment and prevention of a disease caused by expression of a gene controlled by NF-kappaB or ets. The composition comprises at least one decoy and a pharmaceutically acceptable carrier. The decoy is an NF-kappaB decoy, an ets decoy, or a chimera decoy of NF-kappaB and ets. The disease is cerebral aneurysm, cancer, Marfan's syndrome, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic dermatitis, nephritis, renal failure, or plaque rupture. The pharmaceutically acceptable carrier may be a hydrophilic polymer.
|
